Tirzepatide is an investigational peptide compound that functions as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This mechanism has drawn significant interest in the scientific community for its potential applications in metabolic studies, particularly those focused on insulin sensitivity, glycemic control, and obesity-related pathways.
Our Tirzepatide is supplied as a lyophilized powder contained in sterile, unlabeled 10-vial kits, ideal for controlled laboratory environments. Each batch is produced under rigorous quality standards and independently analyzed for purity and composition to ensure reliable and reproducible research outcomes.
Each vial is intended for in vitro use only. Not for human consumption. Not for therapeutic or diagnostic purposes.
